Skip to main content

A willingness-to-pay assessment of parents’ preference for shorter duration treatment of acute otitis media in children

PharmacoEconomics volume 23, pages 1243–1255 (2005)Cite this article

Abstract

Objective: To assess parental willingness to pay (WTP) for a shorter course of antibacterial treatment versus conventional antibacterial therapy for acute otitis media (AOM).

Methods: The study population consisted of 562 parents of children who had been seen and treated by a paediatrician for an episode of AOM between February and November 2002 in Montreal, Quebec, Canada. At the end of the AOM treatment, a questionnaire that included demographic information about the parents and child, details of the child’s AOM history, a global wellbeing (i.e. quality of life) assessment, an evaluation of treatment compliance and a scripted WTP question was administered over the telephone. Descriptive analyses were performed in addition to a multivariate analysis to estimate possible predictors of parental WTP.

Results: The children with AOM were representative of the AOM patient population, with 46% being <2 years of age and the majority attending day-care or school. Parents were willing to pay a median of $Can31.66 (2002 values) for a mono-dose (one dose, on 1 day) and $Can26.63 for a tri-dose (one dose daily, for 3 days) antibacterial treatment. Regression analyses demonstrated that the amount parents were willing to pay was positively associated with increasing household income, increasing number of AOM episodes during the previous year and experiencing adverse effects of treatment.

Conclusion: Parents of children with AOM were willing to pay more for their child to benefit from a shorter duration of antibacterial treatment than for a standard course. Short duration of treatment appears to be associated with better compliance and parents’ perception of better general wellbeing for their child.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

49,54 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Table I
Table II
Table III
Table IV
Table V
Table VI
Fig. 1
Table VII
Table VIII

References

  1. Rovers MM, Schilder AGM, Zielhuis GA, et al. Otitis media. Lancet 2004; 363: 465–73

    PubMed  Article  Google Scholar 

  2. Shriberg LD, Kent RD, Karlsson HB, et al. A diagnostic marker for speech delay associated with otitis media with effusion: backing of obstruents. Clin Linguist Phon 2003; 17 (7): 529–47

    PubMed  Article  Google Scholar 

  3. Rosenfeld RM, Kay D. Natural history of untreated otitis media. Laryngoscope 2003; 113 (10): 1645–57

    PubMed  Article  Google Scholar 

  4. Scott EG, Powell KR. Acute otitis media. Infect Med 2003; 20: 224–9

    Google Scholar 

  5. Harrison CJ, Belhorn TH. Antibiotic treatment failures in acute otitis media. Pediatr Ann 1991; 20 (11): 600–1, 603-8

    PubMed  CAS  Google Scholar 

  6. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for otitis media, sinusitis and tonsillopharyngitis. Paediatr Infect Dis J 1997; 16: 680–95

    Article  CAS  Google Scholar 

  7. Pichicero M. Short courses of antibiotic in acute otitis media and sinusitis infections. J Int Med Res 2000; 28 Suppl. 1: 25A–36A

    PubMed  Google Scholar 

  8. Kaplan B, Wandstrat TL, Cunningham JR. Overall cost in the treatment of otitis media. Paediatr Infect Dis J 1997; 16: s9–11

    Article  CAS  Google Scholar 

  9. Khmana CM. A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school. Paediatr Infect Dis J 1997; 16: 680–95

    Article  Google Scholar 

  10. Cohen R, Levy C, Doit C, et al. Six-day amoxicillin vs ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 1996; 15: 678–82

    PubMed  Article  CAS  Google Scholar 

  11. Ovetchkine P, Cohen R. Shortened course of antibacterial therapy for acute otitis media. Pediatr Drugs 2000; 5 (2): 133–40

    Google Scholar 

  12. Schrag SJ, Phil D, Pena C, et al. Effect of short-course, highdose amoxicillin therapy on resistant pneumococcal carriage. JAMA 2001; 286: 49–56

    PubMed  Article  CAS  Google Scholar 

  13. Toltzis P, Dul M, O’Riordan MA, et al. Impact of amoxicillin on pneumococcal colonization compared with other therapies for acute otitis media. Pediatr Infect Dis J 2005; 24 (1): 24–8

    PubMed  Article  Google Scholar 

  14. Hoppe HL, Johnson CE. Focus on antimicrobial resistance and new treatment options. Am J Health Syst Pharm 1998; 55: 1881–97

    PubMed  CAS  Google Scholar 

  15. Takata GS, Chan LS, Shekelle P, et al. Evidence assessment of management of acute otitis media: the role of antibiotics in the treatment of uncomplicated acute otitis media. Pediatrics 2001; 108: 239–47

    PubMed  Article  CAS  Google Scholar 

  16. Alsarraf R, Jung CJ, Perkins J, et al. Measuring the indirect and direct costs of acute otitis media. Arch Otolaryngol Head Neck Surg 1999; 125: 12–8

    PubMed  CAS  Google Scholar 

  17. Wandstrat TL, Kaplan B. Pharmacoeconomic impact of factors affecting compliance with antibiotic regimens in the treatment of acute otitis media. Pediatr Infect Dis J 1997; 16 (2 Suppl.): S27–9

    PubMed  CAS  Google Scholar 

  18. Ryan M, Scott DA, Reeves C, et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess 2001; 5 (5): 1–186

    PubMed  CAS  Google Scholar 

  19. Lenert L, Kaplan RM. Validity and interpretation of preferencebased measures of health-related quality of life. Med Care 2000; 38 (9 Suppl.): 11138–50

    Google Scholar 

  20. Diener A, O’Brien B, Gafni A. Health care contingent valuation studies: a review and classification of the literature. Health Econ 1998; 7 (4): 313–26

    PubMed  Article  CAS  Google Scholar 

  21. Gafni A. Willingness-to-pay as a measure of benefits: relevant questions in the context of public decision making about health care programs. Med Care 1991; 29 (12): 1246–52

    PubMed  Article  CAS  Google Scholar 

  22. O’Brien B, Gafni A. When do the “dollars” make sense? Toward a conceptual framework for contingent valuation studies in health care. Med Decis Making 1996; 16 (3): 288–99

    PubMed  Article  Google Scholar 

  23. Klose T. The contingent valuation method in health care. Health Policy 1999; 47: 97–123

    PubMed  Article  CAS  Google Scholar 

  24. SAS Institute Inc. SAS/STAT user’s guide. Version 8.0. Cary (NC): SAS Institute Inc, 2000

    Google Scholar 

  25. Sorum PC. Measuring patient preferences by willingness to pay to avoid: the case of acute otitis media. Med Decis Making 1999; 19: 27–37

    PubMed  Article  CAS  Google Scholar 

  26. Arrow K, Solow R, Portney PR, et al. Report of the NOAA panel of contingent valuation. Fed Reg 1994; 58: 4601–14

    Google Scholar 

  27. Olsen JA, Smith RD. Theory versus practice: a review of ‘willingness to pay’ in health and health care. Health Econ 2001; 10: 39–52

    PubMed  Article  CAS  Google Scholar 

  28. Pichichero ME, Casey JR. Acute otitis disease management. Minerva Pediatr 2003; 55: 415–38

    PubMed  CAS  Google Scholar 

  29. Hoppe JE, Blumenstock G, Grotz W, et al. Compliance of German pediatric patients with oral antibiotic therapy: results of a nationwide survey. Pediatr Infect Dis J 1999; 18: 1085–91

    PubMed  Article  CAS  Google Scholar 

  30. Hussar DA. Importance of patient compliance in effective antimicrobial therapy. Pediatr Infect Dis J 1987; 6: 971–5

    PubMed  Article  CAS  Google Scholar 

  31. Meyeroff AS, Weniger BG, Jacobs RJ. Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections. Pediatr Infect Dis J 2001; 20: S57–62

    Article  Google Scholar 

  32. Coyle PC, Asche CV, Elden LM. The economic cost of otitis media in Canada. Int J Pediatr Otorhinolaryngol 1999; 49: 27–36

    Article  Google Scholar 

Download references

Acknowledgements

Sponsorship: this research was supported by an independent research grant provided by Pfizer Canada Inc. The funding agreement ensured the author’s independence in designing the study, interpreting the data, writing and publishing the report.

Delphine Gueylard Chenevier is a PhD candidate and the recipient of a grant from the ‘Fonds de Recherche en Santé du Québec’.

This study is part of Delphine Gueylard Chenevier’s thesis. She has conducted the literature review, studied different methodologic approaches and written the protocol. She coordinated the recruitments and interviews, analysed the results and wrote this manuscript. As mentioned at the end of this manuscript she was helped with statistics and interviews.

Dr Jacques LeLorier is the Director of this thesis. He conducted the research and corrected the manuscript.

Dr Jacques LeLorier has worked as paid consultant for Pfizer Canada Inc.

The authors would like to thank the staff of Ste. Justine’s Hospital and Benoit Bailey MD for coordinating the study. We are grateful to the following physician investigators for enrolling parents into the study: Aly Attye, Jean-Luc Doray, Jean-Pierre Doray, Boris Subic, Stephen Treherme, Pierre Urbanski, Gaelle Vekemans and John Yaremko.

We thank the study interviewers: Severine Delmas, Sanaz Nowrouzzahra and Liliane Roucolle, as well as Marc Dorais and Amir Abbas Tahami Monfared for their assistance with statistics.

Finally, we would like to thank the parents involved in the study who gave their time to complete the interviews, and without whom this study would not have been possible.

Author information

Affiliations

  1. Department of Biomedical Sciences, University of Montreal, Montreal, Canada

    Delphine Gueylard Chenevier

  2. Pharmacoeconomics and Pharmacoepidemiology Research Unit, Centre Hospitalier de l’Université de Montréal Hôtel Dieu, Montreal, Canada

    Delphine Gueylard Chenevier &  Jacques LeLorier

Authors
  1. Delphine Gueylard Chenevier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacques LeLorier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacques LeLorier.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chenevier, D.G., LeLorier, J. A willingness-to-pay assessment of parents’ preference for shorter duration treatment of acute otitis media in children. Pharmacoeconomics 23, 1243–1255 (2005). https://doi.org/10.2165/00019053-200523120-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200523120-00008

Keywords

  • Azithromycin
  • Acute Otitis Medium
  • Antibacterial Treatment
  • Cefprozil
  • Short Duration Treatment